Indusatumab GUCY2C: A Deep Dive into 1497400-26-6 Indusatumab GUCY2C, identified as the chemical code 1497400-26-6, represents a unique therapeutic compound currently under clinical evaluation . This unique molecule combines an GUCY2C-targeting antibody with a potent substance, designed… Read More

Carotuximab, identified as TRC105 or DE-122, represents a unique antibody-drug conjugate ADC currently being studied for combating various malignant diseases. This particular molecule binds to a unique antigen, expressed on cancer cells, delivering a potent cytotoxic substance directly within the… Read More

S2H97 Antibody: The Significant Resource for COVID-19 Research This S2H97 antibody is the important tool for accelerating understanding of COVID-19. Its ability to selectively recognize the viral spike protein enables it extremely useful for a range of uses, such as assessment with the … Read More